Pharmaceutical-Grade Isotretinoin Research Solution
Aknetrent 20 Recordati is a pharmaceutical-grade isotretinoin formulation specifically manufactured for laboratory research applications. This compound represents a standardised preparation of 13-cis-retinoic acid, a synthetic retinoid that has been extensively studied in dermatological research contexts. Developed by Recordati Pharmaceuticals, this formulation maintains strict quality control standards essential for reproducible research outcomes. Investigators studying retinoid pathways and dermatological mechanisms will find this preparation valuable for controlled laboratory investigations.
Laboratory Research Applications
Research teams investigating sebaceous gland biology utilise isotretinoin compounds to examine cellular differentiation pathways and lipid metabolism mechanisms. Studies have explored the compound’s interaction with retinoic acid receptors and its effects on keratinocyte proliferation in cell culture models. Dermatological researchers examine how isotretinoin influences sebocyte apoptosis and comedogenesis inhibition through molecular pathway analysis. The compound serves as a reference standard when investigating retinoid receptor binding affinity and downstream transcriptional effects. Pharmaceutical research laboratories study isotretinoin’s bioavailability characteristics and metabolic transformation pathways. Those seeking comprehensive research compounds can explore our full range at Stroid UK Shop, including our isotretinoin research compounds, alongside our SARM preparations and peptide research tools.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Isotretinoin (13-cis-retinoic acid) |
| Formulation Strength | 20mg per unit |
| Manufacturer | Recordati Pharmaceuticals |
| CAS Number | 4759-48-2 |
| Molecular Formula | C₂₀H₂₈O₂ |
| Molecular Weight | 300.44 g/mol |
| Storage Requirements | Cool, dry conditions, protected from light |
| Research Grade | Pharmaceutical standard |
Research Compliance Information
Aknetrent 20 Recordati is supplied exclusively for in-vitro laboratory research purposes and is not intended for human consumption, therapeutic use, or any clinical application. This product is designed for qualified researchers conducting studies on retinoid pathways, dermatological mechanisms, or pharmaceutical analysis. Investigators must ensure proper laboratory protocols, adequate ventilation, and appropriate disposal procedures when handling this research compound. All research activities should comply with institutional guidelines and regulatory requirements for chemical research substances.
